Skip to content

Body Awareness and Functionality in Lymphedema

Effects of Lymphedema After Breast Cancer Treatment on Body Awareness and Upper Extremity Functionality

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06036173
Enrollment
102
Registered
2023-09-13
Start date
2023-08-16
Completion date
2023-10-27
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema of Upper Limb

Brief summary

To determine whether body awareness and upper extremity functionality are affected in patients with or without lymphedema development after breast cancer surgery in comparison with individuals without a history of cancer.

Interventions

OTHERdiagnosis of lymphedema

being diagnosed with secondary lymphedema in the upper extremity according to the International Lymphedema Association

OTHERbreast cancer surgery

be diagnosed and undergo surgery

Sponsors

Selcuk University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years

Inclusion criteria

first group: * being female, * being aged 18-65 years, * having undergone unilateral breast cancer surgery, * being diagnosed with secondary lymphedema in the upper extremity according to the International Lymphedema Association * not having any orthopedic disease that would prevent walking, and volunteering to participate in the study. second group:The inclusion criteria for the breast cancer surgery group * without lymphedema were being female, * being aged 18-65 years, * having undergone unilateral breast cancer surgery, and volunteering to participate in the study. Lastly, the inclusion criteria for the control group were: * being female, * being aged 18-65 years, * having no history of cancer surgery, and volunteering to participate in the study.

Exclusion criteria

for all groups * not being willing to participate in the study; * the presence of metastases, neurological, or orthopedic disorders; * postural deformities, such as scoliosis and kyphosis; * mental and cognitive disorders; or communication/cooperation problems

Design outcomes

Primary

MeasureTime frameDescription
Body Awareness Questionnaire17 minutesThis instrument consists of a total of 18 items evaluated based on a scale of 1 (not at all true of me) to 7 (very true of me). The total score is obtained by adding the scores of each item. A higher total score indicates better body awareness. Max/ min score:126/18
Quick-Disabilities of the Arm, Shoulder, and Hand questionnaire11 minutesEach of the 11 items in this instrument is scored from 1 to 5. The responses given to all items are summed up, and the total score is obtained with a special formula. A high total score indicates a high level of functional limitation. Max/ min score: 100/0

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026